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Reverse transcription PCR
Reverse transcription (RT)-PCRs were carried out with -actin (ACTB), GAPDH, 3-HSD, eNOS, RIPK1 and RIPK3 primers. The sequence of each primer is shown in supplementary Table 1 and they were used as housekeeping genes (GAPDH and ACTB), markers for LSCs (3-HSD), or marker for LECs (eNOS). As a negative control (N.C.), PCR was performed without any primers. Each PCR yielded only a single amplification product. The PCRs were carried out using an RED Taq ReadyMix PRC Reaction Mix (Sigma-Aldrich, #R2523) and a thermal cycler (BioRad, Hercules, CA, USA). The conditions for the PCRs were as follows: after activation of DNA polymerase by incubating for 7 min at 94 C, 30 cycles of reactions including denaturation for 1 min at 94 C, annealing for 2 min at 55 C, and finally extension for 3 min at 72 C were performed. The PCR amplification was calibrated to determine the optimal number of cycles that would allow detection of the appropriate mRNA transcripts while still keeping amplification of these genes in the log phase. A two-fifths aliquot of each reaction mixture was electrophoresed on a 1.5% agarose gel containing ethidium bromide and photographed under ultraviolet illumination.
Hormone Determinations
Concentrations of P4 were determined directly from the cell culture media by direct enzyme immunoassay. As described previously 1 for P4 concentration assessment, antiserum was used at a final dilution of 1:100, 000. HRP-labeled P4 was used at a final concentration of 1:75, 000. The standard curve ranged from 0.39 to 100 ng/ml, and the concentration of P4 at 50% binding (ED50) was 4.3 ng/ml. The intra-and inter-assay coefficients of variation (CVs)
were 5.6% and 8.8%, respectively. 
Effects of necrostatin-1 (Nec-1) on P4 production in LSCs
The cells were treated with TNF (2.3 nM) + IFNG (2.5 nM) in combination with Nec-1 (50 M)
for 6 h. After culture, P4 concentrations in the supernatants were measured. 
Full length lanes of western blotting
Bands surrounded by red square were quantitated in figure 1 (A and B) , figure 2 (C and D) and figure 7 (E and F), respectively. 
